O consumo de drogas e álcool constitui cada vez mais um problema social e de saúde pública, pelas consequências negativas que provocam no desenvolvimento emocional e físico dos indivíduos. Existem poucas referências na literatura avaliando o uso destas substâncias por portadores de doença falciforme (DF). Estes pacientes apresentam crises álgicas severas, recorrentes, frequentemente controladas por opióides. O comprometimento da qualidade de vida predispõe a ocorrência de transtornos psiquiátricos não-psicóticos, como depressão por exemplo, tornando o grupo vulnerável ao uso abusivo de substâncias. Objetivos: avaliar o consumo de álcool e drogas em pacientes portadores de DF acompanhados pelo Centro de Referência de Doença Falciforme (CRAF) do Hospital de Clínicas de Porto Alegre (HCPA), estimar o percentual de pacientes em tratamento da doença falciforme que fazem uso abusivo de álcool e drogas, e colaborar com o estudo que avaliará a efetividade de um centro de referência multidisciplinar para esta população. Métodos: estudo transversal, de uma amostra de conveniência, com 139 pacientes portadores de DF acompanhados no CRAF do HCPA. Resultados: a prevalência do uso abusivo foi de 1,5% para o álcool e 3,0% para o tabaco, e não se identificou o uso abusivo de outras substâncias, inclusive opióides. O padrão para o uso de substâncias não foi influenciado pela exposição ou por transtornos psiquiátricos não-psicóticos. Conclusão: São necessários mais estudos para reforçar estes achados, mas demonstra-se a segurança do uso de analgésicos opióides para o manejo das crises dolorosas apresentadas pelos portadores de DF. / Drug abuse is increasingly becoming a social and public health problem, because of the negative consequences that such abuse causes on the emotional and physical development of individuals. There are few references in the literature evaluating the use of these substances by individuals with sickle cell disease (SCD). These patients have severe and recurrent pain crises, frequently needing opioids drugs to control it. The compromised quality of life can predispose this population to the occurrence of non-psychotic psychiatric disorders such as depression, making them vulnerable to substance abuse. Objectives: To evaluate the level of consumption of alcohol and drugs in patients with SCD followed by Sickle Cell Disease Reference Center (CRAF) at Hospital de Clínicas de Porto Alegre; to estimate the percentage of patients in treatment of SCD who abuse alcohol and drugs, and to collaborate with the study evaluating the effectiveness of the CRAF. Methods: cross-sectional study of a convenience sample of 139 patients with SCD treated at CRAF. Results: the prevalence of abusive use of the studied population was 1.5% for alcohol and 3.0% for tobacco, and no abusive use of any other substance, including opioids, was identified. It was verified that the pattern for substance use was not influenced by exposure to substances or the presence of non-psychotic psychiatric disorders. Conclusion: More studies are needed to reinforce these findings, but they suggested that the use of opioid analgesics for the management of SCD painful crises is safe and do not induces substance abuse.

Sickle Cell Disease (SCD) is a hereditary monogenic disorder that affects millions of people worldwide and is associated with symptoms such as stroke, lethargy, chronic anemia, and increased mortality. SCD can be quickly detected and diagnosed using a simple blood test as an infant, but as of now, there is currently limited treatment to cure an individual of sickle cell disease. Recently, there have been several promising developments in CRISPR-Cas-associated gene-editing therapeutics; however, there have been limitations in gene-editing efficiency monitoring, which if improved, could be beneficial to advancing CRISPR-based therapy, especially in SCD. The CRISPR-Chip, a three-terminal graphene-based field effect transistor (gFET), was used to detect genomic samples of individuals with SCD, with and without amplification. With the dRNP-HTY3’ complex, CRISPR-Chip was able to specifically detect its target sequence with and without pre-amplification. With the dRNP-MUT3’ complex, CRISPR-Chip was only able to specifically detect one of its two target sequences. Facile detection, analysis, and editing of sickle cell disease using CRISPR-based editing and monitoring would be beneficial for simple diagnostic and gene-editing therapeutic treatment of other single nucleotide polymorphisms as well, such as beta-thalassemia and cystic fibrosis.

The self-care management of sickle cell disease (SCD) improves mortality rate; however, compliance with SCD self-care management remains a problem. The purpose of this study was to examine the knowledge and factors that influence compliance with SCD self-care management recommendations among caregivers of children with SCD. The health belief model was used as the theoretical foundation of this study, theorizing that caregivers' perceived susceptibility, severity, and benefits of SCD self-care management will influence compliance. The study used a quantitative research design. A cross-sectional survey was administered to 100 caregivers of children with SCD attending sickle cell clinics in Lagos, Nigeria using convenience sampling. Information was obtained from participants using a structured interviewer-administered questionnaire, and data were analyzed using descriptive statistics, bivariate correlations, and binary logistic regression techniques. Findings confirmed a high adherence rate but low knowledge of SCD self-care management among the caregivers of children with SCD. There was no significant correlation between knowledge of SCD self-care management and adherence. However, the findings from the multivariate analysis identified knowledge as a predictor of adherence and religiosity and total number of barriers as barriers to adherence. Parental health beliefs did not influence adherence to SCD self-care management. These findings have social change implications by guiding the work of health educators, health care providers, and public health practitioners to incorporate group counseling on SCD self-care management at every sickle cell clinic.

Le premier objectif de cette thèse était de déterminer les effets isolés et combinés de l'alpha thalassémie, des polymorphismes inducteurs (QTLs) de l'HbF et du génotype G6PD dans un contexte d'évolution naturelle de la drépanocytose (Etudes 1 et 2). L'étude 1 a permis d'évaluer pour la première fois les fréquences alléliques de ces gènes modificateurs chez 301 enfants sénégalais SS. Contrairement aux autres populations africaines, le Variant Betica de la G6PD était majoritaire par rapport au variant A(-). De plus, 12% de notre cohorte avait un déficit en G6PD combiné à une absence d'alpha-thalassémie. Ces patients-là seront à privilégier pour la réalisation d'un Doppler transcrânien. Les résultats obtenus dans l'étude 2 nous ont permis de conclure que l'alpha-thalassémie et les QTLs de l'HbF sont interdépendants et ne doivent pas être étudiés séparément pour une prédiction clinique précise. En effet, une combinaison d'alpha-thalassémie avec au moins 2 QTLs de l'HbF est nécessaire pour retarder de manière significative la première complication de la maladie. Cependant, une alpha-thalassémie homozygote, même associée à 3 à 6 QTLs de l'HbF, augmente la fréquence des CVO pendant l'enfance. Par conséquent, une alpha-thalassémie hétérozygote avec au moins deux QTL HbF constituerait le génotype le plus favorable relativement à la survenue des CVO. Le deuxième objectif de cette thèse était d'étudier les interrelations entre le stress oxydant (phénotype et génotype) et la sévérité clinique de la maladie (Etudes 3 à 4). La drépanocytose est caractérisée par un stress oxydatif élevé pouvant expliquer une partie des manifestations cliniques. Nos résultats ont montré que l'alpha-thalassémie homozygote semble diminuer le stress oxydatif, ce qui contribuerait à son effet protecteur sur certaines complications du sous-phénotype hémolytique. En outre, les patients qui ont le moins d'hospitalisations et de CVO semblent présenter une meilleure défense antioxydante (activités catalase et GPx augmentées). Dans l'étude 4 nous avons étudié 4 SNPs de gènes du stress oxydant (rs4880 du gène SOD2, rs207454 du gène XO, rs233322 du gène MPO et rs35652124 du gène NFE2L2). Le SNP rs4880 aurait un effet favorable au niveau biologique (réticulocytose moindre, activité GPx augmentée) mais sans traduction clinique associée. Il en est de même pour rs233322 qui serait associé à une hémolyse et à un stress oxydatif (AOPP) plus importants. En revanche, une tendance à un effet protecteur de rs207454 vis-à-vis de certaines complications (hospitalisations, ostéonécrose, sepsis, STA) a été observée. Notre travail contribue à la compréhension de l'impact des gènes modificateurs dans la drépanocytose. Il pourrait donc permettre, via une sélection positive des patients à risque, d'améliorer la prise en charge de la maladie dans les pays où les traitements de fond (hydroxyurée, doppler transcrânien, échanges transfusionnels) ne peuvent être proposés à tous / The primary objective of this thesis was to determine the isolated and combined effects of alpha-thalassemia, inductors polymorphisms (QTLs) of HbF and genotype G6PD in a context of natural progression of sickle cell disease (Studies 1 and 2). Study 1 was undertaken to evaluate for the first time the allelic frequencies of these modifiers genes in 301 Senegalese SS children. Unlike other African populations, the G6PD Betica Variant was predominant over the A (-) variant. In addition, 12% of our cohort had G6PD deficiency combined with no alpha-thalassemia. These patients will be favoured for the realization of a transcranial doppler. The results obtained in Study 2 allowed us to conclude that alpha thalassemia and QTLs of HbF are interdependent and should not be studied separately for accurate clinical prediction. Indeed, a combination of alpha thalassemia with at least 2 QTLs of HbF is required to significantly delay the first complication of the disease. However, a homozygous alpha thalassemia, even associated with 3 to 6 QTLs of HbF, increases the frequency of CVOs during childhood. Therefore, a heterozygous alpha-thalassemia with at least two QTL HbFs would be the most favourable genotype for the occurrence of CVOs. The second objective of this thesis was to study the interrelationships between oxidative stress and the clinical severity of the disease (Studies 3 to 4). Sickle cell disease is characterized by high oxidative stress that may explain some of the clinical manifestations. Our results showed that homozygous alpha-thalassemia appears to reduce oxidative stress, which would contribute to its protective effect on certain complications of the hemolytic sub-phenotype. In addition, patients with the least hospitalization and CVO appear to have better antioxidant defense (catalase and GPx activities increased). In Study 4 we studied 4 SNPs of oxidative stress genes (rs4880 of the SOD2 gene, rs207454 of the XO gene, rs233322 of the MPO gene and rs35652124 of the NFE2L2 gene). The rs4880 SNP would have a favourable effect on the biological level (less reticulocytosis, increased GPx activity) but without associated clinical translation. The same is true for rs233322, which is associated with greater haemolysis and oxidative stress (AOPP). On the other hand, a tendency to a protective effect of rs207454 for some complications (hospitalizations, osteonecrosis, sepsis, STA) was observed. Our work contributes to the understanding of the impact of modifiers genes in sickle cell disease. It could therefore, through a positive selection of at-risk patients, improve the management of the disease in countries where the basic treatments (hydroxyurea, transcranial doppler, blood transfusion) cannot be offered to all

La drépanocytose est la maladie moléculaire et héréditaire (transmission mendélienne récessive et autosomique) la plus répandue au monde. Elle est un problème de santé publique par sa gravité et ses implications socio-économiques dans de nombreux pays. Seuls les sujets homozygotes (SS) ou hétérozygotes composites (SC) sont malades, les hétérozygotes (AS) ne sont que des transmetteurs du gène S. Elle est la première cause d’OstéoNécrose de la Tête Fémorale (ONTF), douloureuse évoluant vers l’arthrose, en l’absence de traitement chez un patient jeune. La Guadeloupe compte 450.000 habitants, dont 12% sont porteurs de l’hémoglobine S. Le nombre des drépanocytaires est estimé à 1.200 dont les 3/4 sont suivis au Centre Caribéen de la Drépanocytose (CCD), créé en 1990. Le centre assure la prise en charge médicale des enfants dès leur naissance et des adultes malades. Nos activités au CHU de Pointe-à-Pitre, au CCD et à l’Unité INSERM-UMR S458 depuis juillet 1992 nous ont permis d’étudier: - le diagnostic de l’ONTF; - l’évaluation de l’hyperpression osseuse dans l’ONTF et l’évaluation du traitement par forage simple; - l’étude de l’impact de la prise en charge orthopédique précoce sur la survenue et l’évolution de l’ONTF. Notre étude concerne les patients drépanocytaires adultes homozygotes (SS) et double hétérozygotes (SC): - une série rétrospective de 1993-1994 [E-1994] portant sur 115 patients (58 SS, 57 SC) identifiés en 1984, sans suivi médical ni orthopédique; - une série prospective de 1995 à 2008 [E-2008] portant sur 215 patients (94 SS, 121 SC) avec prise en charge médicale et orthopédique. L’IRM est l’examen de référence pour le diagnostic de l’ONTF comme dans la nécrose idiopathique. En absence d’imagerie moderne, la radiographie traditionnelle réalisée de façon complète (profil et, surtout, faux profil), permet le diagnostic avant toute déformation. Seules les lésions cliniquement symptomatiques et évolutives (examen clinique itératif, contrôle radiologique, tomographie, TDM ou IRM) ont une indication opératoire. L’hyperpression intra osseuse, dans l’ONTF drépanocytaire, est significativement liée à la douleur (que les patients soient homozygotes ou hétérozygotes). Sa diminution a un effet antalgique objectif, observée après forage. Elle permet de confirmer le diagnostic d’ostéonécrose au stade précoce, dans les régions où l’IRM est inexistante. Un forage réalisé aux stades précoces de l’ONTF permet un arrêt rapide de l’évolution des lésions vers une arthrose, avec une efficacité certaine pour les stades I et II. Il garde une efficacité limitée pour le stade III. En plus de l’indolence apportée par la décompression, le bénéfice du forage se manifeste par l’allongement du délai avant arthroplastie (de 7,4 ± 2,7 ans). La technique est réalisable dans les régions sous équipées, où la drépanocytose est fréquente. La description histologique aux différents stades radiologiques de l’ONTF montre toujours des lésions de nécrose médullaire et osseuse. A l’inverse des lésions idiopathiques, les lésions drépanocytaires sont caractérisées par la présence d’une inflammation, en dehors de tout processus infectieux. Dans la littérature, la fréquente de l’ONTF drépanocytaire chez l’adulte est voisine de 40%, proche de celle observée dans [E-1994], notre population non suivie (36,5%). En comparant les études [E-1994] et [E-2008], la fréquence de l’ONTF passe de 36,5% à 14,4%. L’officialisation en 1992 d’une prise en charge médicale et d’un suivi orthopédique régulier au CCD et au CHU de Pointe-à-Pitre, a permis la réduction de la fréquence de l’ONTF et d’autres morbidités. Le rappel sur la drépanocytose révèle la complexité de la maladie, la variabilité de son expression clinique et de ses complications. L’amélioration de vie des patients nécessite une prévention primaire, secondaire et tertiaire, en l’absence d’un traitement spécifique de la maladie. La prise en charge médicale, complétée par une prévention et un traitement précoce (orthopédique ou chirurgical) telle que réalisés au CCD en Guadeloupe, a permis une réduction significative de la survenue de la nécrose de hanche et de ses complications. Pour une prévention tertiaire des complications ostéo-articulaires, nous suggérons: - une prise en charge médicale régulière des enfants et des adultes afin de réduire les crises vaso-occlusives; - une éducation des patients à la recherche de signes d’appel de l'ONTF et, aussi, d’autres articulations; - un examen clinique ostéo-articulaire lors des bilans annuels et après toute crise vaso-occlusive; - une attention particulière à l’adolescence (passage enfant-adulte), après une grossesse; - une prise en charge précoce, orthopédique ou chirurgicale conservatrice (forage ou ostéotomie) face à une nécrose, afin de réduire les complications invalidantes de l’ONTF. Sickle-cell anemia is the most widespread hereditary (autosomal recessive Mendelian transmission) molecular pathology in the world. It is a public health issue in many countries, due to its severity and socio-economic impact. Only homozygous (SS) and double heterozygous (SC) subjects are affected, heterozygous (AS) subjects merely transmitting the gene S. Sickle-cell anemia is the most frequent cause of osteonecrosis of the femoral head (ONFH), a painful condition which evolves towards osteoarthritis if not treated at an early age. Guadeloupe has a population of 450,000, 12% of whom are carriers of hemoglobin S. There are estimated to be 1,200 sickle-cell anemia sufferers, three-quarters of whom are followed in the Caribbean Sickle-Cell Center (Centre Caribéen de la Drépanocytose: CCD), which was set up in 1990. The Center provides medical care for adult patients and for children as of birth. Work has been ongoing since July 1992, in the Pointe-à-Pitre University Hospital, the CCD and the INSERM-UMR S458 research unit, focusing on: - diagnosis of ONFH; - bone hyperpressure measurement in ONFH and assessment of simple drilling treatment; - the impact of early orthopedic treatment on the onset and evolution of ONFH. The present study involved homozygous (SS) and double heterozygous (SC) adult sickle-cell anemia patients: - a retrospective series, from 1993 to 1994 [S-1994], including 115 patients (58 SS, 57 SC) identified in 1984, who had no medical or orthopedic care; - a prospective series, from 1995 to 2008 [S-2008], including 215 patients (94 SS, 121 SC), with medical and orthopedic care. MRI is the diagnostic gold-standard in ONFH, as in idiopathic necrosis. Where such modern imaging is not available, complete standard X-ray (lateral and especially false lateral) enables diagnosis to be made before deformity sets in. Surgery is indicated only for clinically symptomatic evolutive lesions on iterative clinical check-up, X-ray control, tomography, CT or MRI. Intraosseous hyperpressure in sickle-cell ONFH shows a significant correlation with pain, in both homozygous and heterozygous patients. Pressure reduction is objectively pain-relieving, as seen after drilling, and can confirm diagnosis of ONFH at an early stage, in places where MRI is not available. Drilling performed in the early stages of ONFH quickly arrests evolution towards osteoarthritis, with proven efficacy in grades I and II, and a certain degree of effectiveness in grade III. Over and above the pain-relief provided by decompression, drilling also enables hip replacement to be postponed, by 7.4±2.7 years. Moreover, the technique is feasible in those under-equipped regions in which sickle-cell disease is widespread. Histologic description of radiologic ONFH stages consistently finds medullary and bone necrosis. In contrast to idiopathic lesions, sickle-cell related lesions show inflammation without any associated infection. In the literature, the frequency of adult sickle-cell ONFH is reported to be nearly 40%, close to the 36.5% found in the S-1994 study of a non-treated population. In the S-2008 study of a population with medical and orthopedic care, ONFH frequency fell to 14.4%. The official provision of medical care and regular orthopedic follow-up in the CCD and Pointe-à-Pitre Hospital has reduced the frequency of ONFH and other morbidities. A review of sickle-cell disease reveals its complexity: the variability of its clinical expression and associated complications. Improving patients’ quality of life requires primary, secondary and tertiary prevention, in the absence of specific treatment. Medical care, supplemented by early prevention and treatment (orthopedic or surgical), as practiced in the Guadeloupe CCD, has significantly reduced the rates of ONFH and associated complications. We recommend the following CCD protocol for tertiary prevention of osteoarticular complications: - regular medical care for children and adults, to reduce the incidence of vaso-occlusive crises; - patient education in alarm signs of osteonecrosis of the femoral head and of other joints; - systematic osteoarticular assessment at yearly check-up and after all vaso-occlusive crises; - special focus on adolescence (child-to-adult transition) and following pregnancy; - early care, both orthopedic and by conservative surgery (drilling or osteotomy), in case of necrosis, to reduce the rate of disabling complications of ONFH

Submitted by Maria Creuza Silva (mariakreuza@yahoo.com.br) on 2013-10-11T18:07:10Z No. of bitstreams: 1 Diss Ana Luísa A. Dias. 2013.pdf: 1131201 bytes, checksum: 498a96f8c9ddea3f178807695314ae95 (MD5) / Approved for entry into archive by Maria Creuza Silva(mariakreuza@yahoo.com.br) on 2013-10-11T18:08:16Z (GMT) No. of bitstreams: 1 Diss Ana Luísa A. Dias. 2013.pdf: 1131201 bytes, checksum: 498a96f8c9ddea3f178807695314ae95 (MD5) / Made available in DSpace on 2013-10-11T18:08:16Z (GMT). No. of bitstreams: 1 Diss Ana Luísa A. Dias. 2013.pdf: 1131201 bytes, checksum: 498a96f8c9ddea3f178807695314ae95 (MD5) Previous issue date: 2013 / A doença falciforme (DF) é uma patologia hematológica hereditária que apresenta impacto significativo à vida das pessoas com a doença e suas famílias. Com base nos dados da triagem neonatal o Ministério da Saúde estima o nascimento de 3500 bebês com a doença a cada ano, com incidência média de 1 a cada 1000 nascidos vivos no país. A Bahia concentra a incidência mais alta, com 1 a cada 650 nascidos vivos, mesmo índice de Salvador, que apresenta cerca de 65 novos casos diagnosticados a cada ano. Estudos destacam-na como uma das alterações genéticas mais comuns no mundo. Apresenta maior incidência na população negra, sendo no Brasil, de três a seis vezes mais comum neste grupo. Com alta morbimortalidade, pode levar a anemia crônica, quadros graves de infecção, crises intensas de dor, AVC, além de poder evoluir para problemas de insuficiência renal, dor crônica, complicações cardiopulmonares, lesões osteoarticulares, entre outras. Entre os agravos crônicos e de difícil tratamento destaca-se a úlcera de perna, feridas que acometem cerca de 20 a 22% das pessoas com DF. Surgem geralmente a partir dos 10 anos de idade, espontaneamente ou derivadas de pequenos traumas, com difícil cicatrização e alto índice de recorrência. Situadas entre o calcanhar e joelho podem ter poucos centímetros ou ocupar grande extensão do membro inferior, afetar uma ou ambas as pernas, permanecendo abertas por anos, até décadas. Este agravo apresenta alto impacto no quotidiano e perspectiva de vida, com repercussões sociais, psicológicas e econômicas. O presente estudo teve como objetivo compreender o itinerário terapêutico de pessoas com histórico de úlcera de perna derivadas de doença falciforme, considerando a vivência do adoecimento antes e após o surgimento da ferida crônica, bem como o olhar dos sujeitos sobre a sua trajetória em busca de cuidado. Trata-se de estudo qualitativo baseado em história de vida, que adotou como estratégias as entrevistas narrativa e semi-estruturada aliadas a construção de diário de campo, sendo a análise dos dados realizada á luz da antropologia interpretativa de Gertz. Teve como sujeitos nove adultos com DF, três homens e seis mulheres, com idades variando entre 27 e 54 anos de idade. Todos são moradores de bairros populares, oriundos de famílias de baixa renda e se autodeclararam negros. Os participantes guardam histórias diferentes na relação com a úlcera de perna, tanto no que se refere ao tempo de surgimento do agravo, que variou entre 7 e 40 anos de convivência com a ferida, quanto no tipo de úlcera, pois envolveu pessoas com lesões contínuas e recorrentes, além de ter incluído pessoas cujas lesões estavam cicatrizadas. Percebeu-se que a úlcera de perna se configura como um ruptura biográfica na vida das pessoas com DF, trazendo grande impacto em diversas dimensões da vida como trabalho, estudo, lazer e com acentuado isolamento social. Destaca-se intensa peregrinação em busca de cuidado, tanto a doença falciforme, quanto especificamente a lesão. Foram comuns experiências de descaso e sofrimento desnecessário vivenciados nos serviços de saúde, levando a interferências marcantes na reorganização do itinerário terapêutico em curso. Os participantes evidenciaram que se recusam a se submeter a tratamentos percebidos como inadequados, deixando estes serviços, indo a outros, ou optando por cuidar de si mesmos fora dos serviços de saúde. Destaca-se a necessidade de olhar esta trajetória a partir da história da doença, que inclui as marcas do racismo institucional. Faz-se necessário reconhecer a invisibilidade que estas pessoas enfrentaram, que deixaram marcas físicas e subjetivas, como forma de poder perceber as necessidades de saúde desta população, prestando uma atenção verdadeiramente integral e equânime. / Salvador

Submitted by Ana Maria Fiscina Sampaio (fiscina@bahia.fiocruz.br) on 2012-07-20T20:46:00Z No. of bitstreams: 1 Joelma Figueiredo Menezes Estudo de polimorfismos....pdf: 11425878 bytes, checksum: 175372593b635c3bd50b3a10af52fc30 (MD5) / Made available in DSpace on 2012-07-20T20:46:00Z (GMT). No. of bitstreams: 1 Joelma Figueiredo Menezes Estudo de polimorfismos....pdf: 11425878 bytes, checksum: 175372593b635c3bd50b3a10af52fc30 (MD5) Previous issue date: 2010 / Fundação Oswaldo Cruz. Centro de Pesquisas Gonçalo Moniz. Salvador, Bahia, Brasil / Indivíduos com doença falciforme (DF) apresentam estresse oxidativo (EO) constante, que é decorrente da deficiência nos sistemas antioxidantes, caracterizados pela produção de espécies reativas do oxigênio (EROS) de origem multifatorial, principalmente geradas pelo processo hemolítico. Objetivo. Investigar polimorfismos relacionados ao estresse oxidativo nos genes HFE da hemocromatose hereditária (c.282C>Y, c.63H>D e c.65S>C); haptoglobina (HP), glutationa S-transferase (GST) (GSTT1 e GSTM1) e paraoxonase (PON1) (c.55L>M e c.192Q>R), associando-os aos dados hematológicos e bioquímicos, aos níveis séricos de vitamina C, paraoxonase 1 e receptor de transferrina e histórico clínico de pacientes com doença falciforme. Casuística e Métodos. A casuística foi composta por 153 indivíduos com DF (HbSS e HbSC) e 196 crianças saudáveis. O perfil de hemoglobinas foi determinado por HPLC. Os polimorfismos nos genes HFE, HP, GST, PON1, a presença da talassemia alfa 3,7Kb e 4,2Kb e dos haplótipos ligados ao grupo de genes da globina beta foram investigados por PCR e PCR-RFLP. A avaliação do perfil lipídico, hepático, função renal, inflamatório e metabolismo do ferro foram realizadas por técnicas espectrofotométricas. Os níveis séricos de vitamina C, receptor de transferrina solúvel e hemeoxigenase 1 total foram detectados por ELISA. Resultados. O estudo de polimorfismos no gene da GST demostrou que o genótipo Mu nulo foi o mais frequente em ambos os grupos estudados; a análise hematológica , nos indivíduos HbSS revelou diferença significante para os parâmetros de leucócitos (p=0,0452), de segmentados neutrófilos (p=0,0224) e o evento de STA (p=0,0423); nos indivíduos com DF foram encontradas diferenças para a uréia (p=0,0288) e ferritina (p=0,0316). No estudo do gene da Haptoglobina nos indivíduos com DF encontrou-se diferença significativa para contagem de reticulócitos (p=0,0167), ferritina sérica (p=0,0493); contagem de linfócitos típicos (p=0.0422) e LDH (p=0,0181); nos HbSS encontrou-se diferença para creatinina (p=0,0178) e ALT (p=0,0127). Para o gene HFE foi encontrada diferença significativa entre os alelos selvagem e mutante para o polimorfismo c.63H>D e contagem de plaquetas (p=0,0311) em indivíduos com DF; para o polimorfismo c.65S>C observou-se diferenças estatisticamente significativas para hemoglobina (p=0,0044) e hematócrito (p=0,0078). Nos HbSC para o polimorfismo c.63H>D observou-se entre os alelos selvagem e mutante diferenças significativas com o VCM (p=0,0032), HCM (p=0,0010) e linfócitos típicos (p=0,0242). Entre os indivíduos HbSS observou-se diferença significativa entre os alelos estudados e plaquetas (p=0,0078). Para a mutação c.65S>C observou-se diferenças significativas para os parâmetros de hemoglobina (p=0,0265) e hematócrito (p=0,0407) nos indivíduos HbSS e hemoglobina (p=0,0051) e hematócrito (p=0,0060) nos indivíduos HbSC. A análise do histórico clínico dos indivíduos com DF e o polimorfismo c.63H>D demonstrou diferença significativa para esplenomegalia, OR=3,38 (0,93 -12,22) e p=0,0402. Nos indivíduos HbSS foi encontrada diferença significativa entre os alelos c.63H>D e infecção, com OR=0,29 (0.07 -1,18) e p=0,0455. Para o gene PON1, a avaliação da atividade da PON1 nos indivíduos DF entre os alelos selvagem e mutante revelou diferença estatisticamente significativa, tendo o alelo selvagem maior atividade da PON1 que alelo mutante; para o polimorfismo PON1c.192Q>R observou-se entre os alelos selvagem e mutante diferenças significativas para as variáveis bioquímicas VLDL-C (p=0,0267) e triglicérides (p=0,0127). Nos HbSC verificou-se diferença estatística significativa para o PON1c.192Q>R e concentração de hemoglobina (p=0,0459), hematócrito (p=0,0225) e contagem de linfócitos típicos (p=0,0364). Para o PON1c.55L>M observou-se diferença significativa com a idade (p=0,0139), plaquetas (p=0,0109), creatinina (p=0,0329) e PCR (p=0,0141). Observou-se associação entre atividade da PON1 e esplenectomia (p=0,001); para hemeoxigenase e ferro sérico (p=0,023); e para vitamina C observamos correlação com colesterol HDL (p=0,037). Há correlação entre glutationa e vitamina C (p=0,035).Conclusões: Os polimorfismos estudados podem estar agindo sinergicamente com a hemoglobina variante S e assim influenciar na gravidade da doença, necessitando de outros estudos para validar estes resultados, uma vez que algumas destas investigações foram realizadas pela primeira vez neste grupo de indivíduos. / Patients with sickle cell disease (SCD) has continued oxidative stress (OS), which is resulting from ineffective antioxidant systems, characterized by production of reactive oxygen species (ROS) of multifactorial origin, mainly generated by the hemolytic process. Objective: To investigate polymorphism related to oxidative stress in hereditary hemochromatosis HFE gene (c.282C>Y, c.63H>D c.65S and D>C), haptoglobin (HP), glutathione S-transferase (GST) (GSTT1 and GSTM1) and paraoxonase (PON1) (c.55L>M and c.192Q>R), in association with the hematological and biochemical data, serum levels of vitamin C, paraoxonase 1, transferrin receptor and clinical manifestations of SCD patients. Methods. The sample included 153 individuals with SCD (HbSS and HbSC) and 196 healthy children. The profile of hemoglobin was determined by HPLC. The HFE gene polymorphisms, HP, GST, PON1, the presence of alpha thalassemia 3.7 Kb, 4.2 Kb and haplotypes of the beta gene cluster were investigated by PCR and PCR-RFLP. The lipid profile, liver, renal function, inflammation and iron metabolism was performed by spectrophotometric techniques. Serum levels of vitamin C, soluble transferrin receptor and total hemeoxigenase were investigated by ELISA. Results: The GST Mu null genotype was more frequent in both groups and both polymorphisms were in Hardy-Weinberg equilibrium. In the HbSS observed significant differences in the parameters of leukocytes (p = 0.0452) and segmented neutrophils (p = 0.0224) and event STA (p = 0.0423). Individuals with SCD had differences for urea (p = 0.0288) and ferritin (p = 0.0316). Evaluating the Haptoglobin gene in individuals with SCD found a significant difference for reticulocyte count (p = 0.0167), serum ferritin (p = 0.0493); typical lymphocyte count (p = 0.0422) and LDH (p = 0.0181); in the HbSS were found differences for creatinine (p = 0.0178) and ALT (p = 0.0127). For the HFE gene was found significant differences were observed between wild and mutant alleles for the polymorphism c.63H> D and platelet count (p = 0.0311) in individuals with SCD; for polymorphism c.65S> C were differences were statistically significant for hemoglobin (p = 0.0044) and hematocrit (p = 0.0078). In the HBSC observed significant differences in MCV (p = 0.0032), MCH (p= 0.0010) and typical lymphocytes (p = 0.0242). Among subjects HbSS were observed significant differences between alleles and platelets (p = 0.0078). For mutation c.65S> C showed significant differences in the parameters of hemoglobin (p=0.0265) and hematocrit (p=0.0407) in HbSS individuals, and hemoglobin (p=0.0051) and hematocrit (p=0.0060) in subjects HbSC. The analysis of the clinical history of individuals with SCD and polymorphism c.63H> D there was a significant difference for splenomegaly, OR = 3.38 (0.93 -12.22) and p = 0.0402. In HbSS individuals significant difference was found between alleles c.63H> D and infection, with OR = 0.29 (0.07 -1.18) p = 0.0455. For the PON1 gene, The activity assessment of PON1 in the individuals DF with wild and mutant genotypes showed statistically significant differences, the wild-type allele showed higher PON1 activity than the mutant allele; for the biochemical parameters to polymorphism PON1c.192Q> R and the values of VLDL-C (p = 0.0267) and triglycerides (p = 0.0127). In HbSC there was a statistically significant difference for PON1c.192Q> R and hemoglobin (p = 0.0459), hematocrit (p = 0.0225) and typical lymphocyte count (p = 0.0364). For PON1c.55L> M there was significant difference with age (p = 0.0139), platelets (p = 0.0109), creatinine (p = 0.0329) and CRP (p= 0.0141). There was an association between PON1 activity and splenectomy (p = 0.001) for hemeoxigenase and serum iron (p = 0.023), and vitamin C showed a correlation with HDL cholesterol (p = 0.037). There is a correlation between glutathione and vitamin C (p=0.035) Conclusions: The polymorphisms could be acting synergistically with this hemoglobin variant S, and influence the severity of disease, have been necessary further studies to validate these results, since some of these investigations were performed for the first time in this group of individuals.

Submitted by Ana Maria Fiscina Sampaio (fiscina@bahia.fiocruz.br) on 2012-07-20T21:34:48Z No. of bitstreams: 1 Larissa Carneiro Rocha.pdf: 1632038 bytes, checksum: 82deed6171da78f07c96b948629b2896 (MD5) / Made available in DSpace on 2012-07-20T21:34:48Z (GMT). No. of bitstreams: 1 Larissa Carneiro Rocha.pdf: 1632038 bytes, checksum: 82deed6171da78f07c96b948629b2896 (MD5) Previous issue date: 2011 / Fundação Oswaldo Cruz. Centro de Pesquisas Gonçalo Moniz. Salvador, Bahia, Brasil / A doença falciforme (DF) possui prevalência mundial elevada e manifestação clinicamente variável, sendo que as infecções constituem risco elevado e causa de óbito nas crianças diagnosticadas com anemia falciforme (HbSS). A colonização da nasofaringe pode ser fator importante para a ocorrência de doença local ou sistêmica. O Streptococcus pneumoniae é um patógeno de importância epidemiológica mundial e causador de infecções entre os pacientes com DF. A prevalência da colonização pelo pneumococo em nasofaringe varia de acordo com a população estudada e condições ambientais. O Staphylococcus aureus também pode colonizar a nasofaringe, além de causar infecção de pele e tecidos moles, pneumonia, septicemia e infecções ósteo-articulares. Diferentes biomarcadores têm sido associados à modulação clínica na DF e eles são comumente associados à hemólise e inflamação. O presente estudo teve como objetivo estabelecer o perfil de biomarcadores em indivíduos com DF associando-os ao perfil de colonização nasofaríngea e orofaríngea, com ênfase para os marcadores de infecção e hemólise que possam estar associados ao prognóstico clínico dda doença. As análises bioquímicas foram realizadas para a avaliação do perfil lipídico, hepático, inflamatório e hemolítico; marcadores clássicos de biologia molecular, como a talassemia α, os haplótipos ligados aos genes da globina beta e os polimorfismos no gene da mieloperoxidase foram também investigados. Desta forma, foi desenvolvido um estudo de corte transversal, com casuística composta por 154 pacientes com DF em idade pediátrica e em estado estável da doença, sendo 68,2% (105/154) HbSS e 31,8% (49/154) com doença SC (HbSC), todos provenientes do estado da Bahia. As crianças HbSS apresentaram diferenças significativas na grande maioria das variáveis laboratoriais analisadas e associadas ao metabolismo lipídico, renal, hepático e à hemólise e inflamação, quando comparadas ao grupo HbSC e ao controle saudável. A colonização em nasofaringe/orofaringe pelo S. pneumoniae esteve presente em 14 (9,6%) pacientes e pelo S. aureus em 81(56,6%) pacientes. Quanto ao perfil de sensibilidade dos isolados de pneumococos da população estudada, não foi observado o aumento da resistência pneumocócica à penicilina. A avaliação de modelos de análise multivariada demonstrou que a presença de colonização nasofaríngea e orofaríngea esteve associada à ocorrência de infecção juntamente com a contagem de leucócitos, sendo que o genótipo exibido pelo paciente foi fator de risco para a ocorrência de pneumonia. Os mesmos modelos apontaram o envolvimento dos polimorfonucleares neutrófilos na ocorrência de vaso-oclusão. Os resultados demonstram que os pacientes colonizados em nasofaringe pelo S. pneumoniae e pelo S. aureus apresentaram elevação dos valores de HCM, VCM, AST, ALT e Ferritina; investigações rotineiras de biomarcadores clássicos associados ao estudo da colonização de nasofaringe e orofaringe podem ter papel importante no acompanhamento da evolução clinica de indivíduos com DF, uma vez que os achados significativos sugerem que a presença de colonização tem papel importante na modulação dos eventos hemolítico, inflamatório e infeccioso presentes na doença. / The sickle cell disease (SCD) has a high prevalence worldwide and a variable clinical manifestation and infections are considered an event of high risk and cause of death in children diagnosed with sickle cell anemia (HbSS). The colonization of nasopharynx and oropharynx can be an important factor for the occurrence of local or systemic disease. The Streptococcus pneumoniae is a pathogen of epidemiological importance worldwide and cause of infection among SCD patients. The Staphylococcus aureus may also colonize the nasopharynx and may be cause of infection of skin and soft tissue infections, pneumonia, sepsis and osteo-articular infections. Different biomarkers have been associated with clinical modulation in SCD and they are commonly associated with hemolysis and inflammation. This study aimed to establish a profile of biomarkers in individuals with SCD in association with the profile of oropharyngeal and nasopharyngeal colonization, with emphasis on infection and hemolysis markers that may be associated with clinical prognosis. Biochemical analysis were performed to evaluate the lipid profile, liver, hemolytic and inflammatory markers and classical molecular biology, such as α-thalassemia, the haplotypes linked to the beta globin genes and polymorphisms in the myeloperoxidase gene were also investigated. Thus, it was developed a cross-sectional study and the casuistic was composed of 154 children with SCD in a steady-state, with 68.2% (105/154) HbSS and 31.8% (49/154) with SC disease (HbSC), all from the state of Bahia. HbSS children showed significant differences in almost every mean values analyzed for variables associated with lipid metabolism, kidney, liver and hemolysis and inflammation when compared to HbSC and control group. In the present study there was colonization in the nasopharynx / oropharynx by S. pneumoniae in 14 (9.6%) patients and by S. aureus in 81 (56.6%) patients. The profile of sensitivity of pneumococcal isolated from the studied population did not show an increase in pneumococcal resistance to penicillin. The evaluation of models of multivariate analysis showed that the presence of oropharyngeal and nasopharyngeal colonization was associated with the occurrence of infection and white blood cell count, and the patient genotype was a risk factor for the occurrence of pneumonia. The same models indicated the involvement of polymorphonuclear neutrophils in the occurrence of vaso-occlusion. The results presented in this study demonstrate that patients colonized in the nasopharynx by S. pneumoniae and S. aureus have elevated values of MCH, MCV, AST, ALT and ferritin, suggesting that a routine investigation of biomarkers associated with the classic study of the colonization of the nasopharynx and oropharynx may play a role in monitoring the clinical course of patients with SCD, once that significant findings described here suggest that the presence of colonization plays an important role in modulation of hemolytic events, inflammatory state, and infectious presented by patients.

O consumo de drogas e álcool constitui cada vez mais um problema social e de saúde pública, pelas consequências negativas que provocam no desenvolvimento emocional e físico dos indivíduos. Existem poucas referências na literatura avaliando o uso destas substâncias por portadores de doença falciforme (DF). Estes pacientes apresentam crises álgicas severas, recorrentes, frequentemente controladas por opióides. O comprometimento da qualidade de vida predispõe a ocorrência de transtornos psiquiátricos não-psicóticos, como depressão por exemplo, tornando o grupo vulnerável ao uso abusivo de substâncias. Objetivos: avaliar o consumo de álcool e drogas em pacientes portadores de DF acompanhados pelo Centro de Referência de Doença Falciforme (CRAF) do Hospital de Clínicas de Porto Alegre (HCPA), estimar o percentual de pacientes em tratamento da doença falciforme que fazem uso abusivo de álcool e drogas, e colaborar com o estudo que avaliará a efetividade de um centro de referência multidisciplinar para esta população. Métodos: estudo transversal, de uma amostra de conveniência, com 139 pacientes portadores de DF acompanhados no CRAF do HCPA. Resultados: a prevalência do uso abusivo foi de 1,5% para o álcool e 3,0% para o tabaco, e não se identificou o uso abusivo de outras substâncias, inclusive opióides. O padrão para o uso de substâncias não foi influenciado pela exposição ou por transtornos psiquiátricos não-psicóticos. Conclusão: São necessários mais estudos para reforçar estes achados, mas demonstra-se a segurança do uso de analgésicos opióides para o manejo das crises dolorosas apresentadas pelos portadores de DF. / Drug abuse is increasingly becoming a social and public health problem, because of the negative consequences that such abuse causes on the emotional and physical development of individuals. There are few references in the literature evaluating the use of these substances by individuals with sickle cell disease (SCD). These patients have severe and recurrent pain crises, frequently needing opioids drugs to control it. The compromised quality of life can predispose this population to the occurrence of non-psychotic psychiatric disorders such as depression, making them vulnerable to substance abuse. Objectives: To evaluate the level of consumption of alcohol and drugs in patients with SCD followed by Sickle Cell Disease Reference Center (CRAF) at Hospital de Clínicas de Porto Alegre; to estimate the percentage of patients in treatment of SCD who abuse alcohol and drugs, and to collaborate with the study evaluating the effectiveness of the CRAF. Methods: cross-sectional study of a convenience sample of 139 patients with SCD treated at CRAF. Results: the prevalence of abusive use of the studied population was 1.5% for alcohol and 3.0% for tobacco, and no abusive use of any other substance, including opioids, was identified. It was verified that the pattern for substance use was not influenced by exposure to substances or the presence of non-psychotic psychiatric disorders. Conclusion: More studies are needed to reinforce these findings, but they suggested that the use of opioid analgesics for the management of SCD painful crises is safe and do not induces substance abuse.

Introdução: a doença falciforme é uma alteração hereditária, que causa malformação nas hemácias com consequências vaso-oclusivas de potencial dano auditivo. Os estudos que tratam da relação entre alteração auditiva e doença falciforme apresentam grande disparidade de resultados. Em todos os trabalhos consultados, não foram encontrados artigos sobre o potencial evocado auditivo com estímulo de fala nesta população. Objetivo: analisar as respostas obtidas pelos potenciais evocados auditivos em crianças, adolescentes e jovens com a doença falciforme. Métodos: trata-se de um estudo observacional, transversal, com amostra de sujeitos com diagnóstico de doença falciforme, advindos de um ambulatório de hemoglobinopatia de um hospital público, localizado no sul do país. A avaliação audiológica ocorreu após liberação médica e foi realizada por meio dos seguintes procedimentos: anamnese, audiometria tonal liminar, audiometria tonal de altas frequências, timpanometria, emissão otoacústica evocada transiente, potencial evocado auditivo de tronco encefálico com estímulo clique (PEATE) e com estímulo de fala (PEATE-f). Resultados: a amostra foi constituída de 54 sujeitos, com idade entre seis e 24 anos. Em relação ao PEATE, verificou-se alteração em 88,9% da amostra, com diferença estatisticamente significativa no aumento da latência absoluta da onda V (p=0,009) e no interpico I-III (p=0,004), no grupo do sexo masculino (p=0,028). A faixa etária em que a alteração mais se evidenciou foi a dos adolescentes (12 a 18 anos) (p=0,017). Quanto ao PEATE-f, 98,1% da amostra apresentaram alguma alteração, mas não houve diferença estatisticamente significativa entre os gêneros. A latência da onda A foi mais tardiamente detectada na orelha esquerda, na faixa etária da adolescência (p=0,021). Conclusões: verificou-se que a maior parte dos sujeitos da amostra apresentou alterações no PEATE e PEATE-f, apesar de possuir limiares auditivos, medidas de imitância acústica e emissões otoacústicas evocadas transientes normais. É recomendável, portanto, que a avaliação auditiva dos indivíduos com a doença falciforme inclua a pesquisa de potenciais evocados auditivos, visando ao diagnóstico e ao encaminhamento para tratamento específico, tendo em vista a adequada capacidade de compreensão de fala e a prevenção de distúrbios linguísticos, biopsicoemocionais e sociais. / Introduction: sickle cell disease is a hereditary disorder that causes malformation in the red blood cells with vaso-occlusive consequences of potential hearing damage. Studies that deal with the relationship between auditory alteration and sickle cell disease present a great disparity of results. In all the studies consulted, no articles on the auditory evoked potential with speech stimulus in this population were found. Objective: to analyze the responses obtained by evoked auditory brainstem response in children, adolescents and young people with sickle cell disease. Methods: it is an observational, cross-sectional study with a sample of subjects with sickle cell disease diagnosed from a hemoglobinopathy outpatient clinic located in the south of the country. The audiological evaluation occurred after medical release and was performed through the following procedures: anamnesis, tonal threshold audiometry, high frequency tone audiometry, tympanometry, transient evoked otoacoustic emission, evoked auditory brainstem response (ABR) and peech-evoked auditory brainstem response (cABR). Results: the sample consisted of 54 subjects, from six to 24 years old. In relation to ABR, there was change in 88,9% of the sample, with a statistically significant difference in the increase of the absolute latency of the V wave (p = 0.009) and in the interpeak I-III (p = 0.004) in the male group (p = 0.028). The age group in which the change was most evident was the adolescent (12 to 18 years) (p = 0.017). Concerning cABR, 98,1% of the sample had some alteration, but there was no statistically significant difference between the genders. The latency of wave A was later detected in the left ear in the adolescence age group (p = 0.021). Conclusions: It was verified that most of the subjects of the sample presented alterations in ABR and cABR, despite having auditory thresholds, acoustic immitance measures and normal transient evoked otoacoustic emissions. It is recommended, therefore, that the auditory evaluation of individuals with sickle cell disease should include the search for auditory evoked potentials, aiming at diagnosis and referral for specific treatment, in view of the adequate ability to understand speech and the prevention of language disorders, biopsychological and social.